Stocks and Investing Stocks and Investing
Wed, April 3, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Mike Hickey Reiterated (BRAG) at Buy and Held Target at $8 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Joanne Wuensch Maintained (BSX) at Strong Buy with Increased Target to $79 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
John Eade Maintained (BSX) at Strong Buy with Increased Target to $80 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Eric Beder Reiterated (BWMX) at Strong Buy and Held Target at $23 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Kevin Caliendo Maintained (WBA) at Hold with Decreased Target to $22 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Charles Ryhee Maintained (WBA) at Strong Buy with Decreased Target to $35 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
George Hill Maintained (WBA) at Hold with Decreased Target to $22 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Timothy Horan Maintained (VZ) at Buy and Held Target at $48 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Anna Andreeva Reiterated (WSM) at Hold on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Philip Gibbs Maintained (ws) at Buy with Increased Target to $40 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Gary Mobley Downgraded (WOLF) to Hold and Decreased Target to $30 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Michael Sison Maintained (WLK) at Buy with Increased Target to $180 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Pavel Molchanov Maintained (wkc) at Buy with Increased Target to $32 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Hartaj Singh Maintained (BMEA) at Buy and Held Target at $70 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Patrick Donnelly Downgraded (BIO) to Hold and Decreased Target to $365 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Naved Khan Initiated (BKNG) at Strong Buy on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Scott Buck Initiated (BKSY) at Strong Buy and Held Target at $20 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Timothy Horan Maintained (TMUS) at Buy and Held Target at $190 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Amit Dayal Reiterated (TOMZ) at Strong Buy and Held Target at $3.5 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Joanne Wuensch Maintained (TNDM) at Hold with Increased Target to $38 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Michael Tyndall Maintained (TSLA) at Sell with Decreased Target to $138 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Ryan Brinkman Maintained (TSLA) at Sell with Decreased Target to $115 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
William Stein Reiterated (TSLA) at Hold with Decreased Target to $176 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Ben Kallo Maintained (TSLA) at Buy with Decreased Target to $280 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Emmanuel Rosner Maintained (TSLA) at Strong Buy with Decreased Target to $189 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Thomas Palmer Maintained (TSN) at Hold with Increased Target to $62 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
John Lawrence Reiterated (TSCO) at Strong Buy and Held Target at $256 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Gabriel Moreen Maintained (TRGP) at Strong Buy with Increased Target to $130 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Joanne Wuensch Maintained (SYK) at Strong Buy with Increased Target to $406 on, Apr 3rd, 2024
[ Wed, Apr 03rd 2024 ] - WOPRAI
Edward Tenthoff Reiterated (SYRS) at Buy and Held Target at $13 on, Apr 3rd, 2024

Edward Tenthoff Reiterated (SYRS) at Buy and Held Target at $13 on, Apr 3rd, 2024


Published on 2024-10-28 10:03:59 - WOPRAI, Edward Tenthoff
  Print publication without navigation


Edward Tenthoff of Piper Sandler, Reiterated "Syros Pharmaceuticals, Inc." (SYRS) at Buy and Held Target at $13 on, Apr 3rd, 2024.

Edward has made no other calls on SYRS in the last 4 months.



There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, 0 agree with Edward's Rating of Hold.



This is the rating of the analyst that currently disagrees with Edward

  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Monday, April 1st, 2024
Contributing Sources